News & Articles

The detection of these antibodies could help indicate if a person has gained immunity against the virus and inform treatment decisions

The only FDA-approved test that measures G6PD provides key insight to inform drug therapy options

The serology immunoassay kit aims to help clinicians diagnose the coronavirus by analyzing the immune response against SARS-CoV-2

The strategic partnership with Australian National Phenome Centre (ANPC) aims to support the work of their researchers

Vehicle manufacturer utilizes infrastructure to expand production to face masks and gowns for frontline medical staff

With medical equipment in short supply, the 3D printing company steps up in coronavirus crisis

Alliance for the scale-up of a GMP manufacturing process and production of a coronavirus (SARS-CoV-2) vaccine (ChAdOx1 nCoV-19) formed

Recognition comes as the publisher launches a series of Virtual Summits to support the science industry through the COVID-19 crisis

The FreeStyle Libre 14 day system can be used by frontline healthcare workers tackling the coronavirus

Test runs on Bio-Rad’s QX200 and QXDx ddPCR systems and aims to provide early detection of COVID-19

Studies in China show that the QX200 ddPCR systems can detect low levels of infection in individuals

The partnership aims to launch a ready-to-go processing solution that streamlines viral DNA/RNA extraction

Recent funding from the BARDA award helped the company accelerate development and validation

The scientific community is working at full speed to fight the severe acute respiratory syndrome

Samples from those who had COVID-19 could reveal true infection rate, lethality and vaccines

The partnership with Primer Design aims to distribute the Genesig CE-IVD & FDA-EUA COVID-19 qPCR kit to Europe and the U.S.

The RAPIDPoint 500e blood gas analyzer aims to meet the unprecedented demand for blood gas testing in coronavirus patients

The Abbott ID NOW™ COVID-19 test aims to bring rapid testing to the front lines of the global pandemic

This clinical trial aims to test the effects of potential drug treatments for patients with the novel coronavirus

The Xpert Xpress SARS-CoV-2 test is designed for the qualitative detection of the virus causing COVID-19

The collaboration aims to develop novel, targeted treatments to address significant unmet needs

Scientists say early data, generated with new NGS research panel from Thermo Fisher Scientific, suggest coronavirus is genetically stable, and could increase the effectiveness of vaccines in development

Sartorius supports the development of the first vaccine candidate against the novel coronavirus to enter clinical trials